Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa.

× No keyword cloud information.

11 in total

1. Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.

Authors: Helio S Sader; Mariana Castanheira; Dee Shortridge; Rodrigo E Mendes; Robert K Flamm
Journal: Antimicrob Agents Chemother Date: 2017-10-24 Impact factor: 5.191

Review 2. Antimicrobial Resistance in ESKAPE Pathogens.

Authors: David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker
Journal: Clin Microbiol Rev Date: 2020-05-13 Impact factor: 26.132

Review 3. Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon?

Authors: Lynn Nguyen; Joshua Garcia; Katherine Gruenberg; Conan MacDougall
Journal: Curr Infect Dis Rep Date: 2018-06-06 Impact factor: 3.725

4. Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration.

Authors: Eric Wenzler; Kristen L Bunnell; Susan C Bleasdale; Scott Benken; Larry H Danziger; Keith A Rodvold
Journal: Antimicrob Agents Chemother Date: 2017-06-27 Impact factor: 5.191

5. Inhibition Activity of Avibactam against Nocardia farcinica β-Lactamase FAR_IFM10152.

Authors: David Lebeaux; Clément Ourghanlian; Delphine Dorchène; Daria Soroka; Zainab Edoo; Fabrice Compain; Michel Arthur
Journal: Antimicrob Agents Chemother Date: 2020-01-27 Impact factor: 5.191

6. Successful Treatment of Ventriculitis Caused by MDR/XDR Gram-Negative Bacillus Using Ceftazidime/Avibactam: Case Series and Literature Review.

Authors: Xiaofeng Yang; Liang Wen; Qian Zhou; Hao Wang; Tianxiang Zhan
Journal: Infect Drug Resist Date: 2021-05-05 Impact factor: 4.003

7. Multidrug-resistant Pseudomonas aeruginosa from sputum of patients with cystic fibrosis demonstrates a high rate of susceptibility to ceftazidime-avibactam.

Authors: Stan D Atkin; Shadaan Abid; Michael Foster; Moumita Bose; Ashley Keller; Rita Hollaway; Helio S Sader; David E Greenberg; James D Finklea; Mariana Castanheira; Raksha Jain
Journal: Infect Drug Resist Date: 2018-09-17 Impact factor: 4.003

8. Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales.

Authors: Antonio Vena; Daniele Roberto Giacobbe; Nadia Castaldo; Annamaria Cattelan; Cristina Mussini; Roberto Luzzati; Francesco Giuseppe De Rosa; Filippo Del Puente; Claudio Maria Mastroianni; Antonio Cascio; Sergio Carbonara; Alessandro Capone; Silvia Boni; Chiara Sepulcri; Marianna Meschiari; Francesca Raumer; Alessandra Oliva; Silvia Corcione; Matteo Bassetti
Journal: Antibiotics (Basel) Date: 2020-02-09

9. Plasma and Cerebrospinal Fluid Therapeutic Drug Monitoring of Ceftolozane and Tazobactam During Treatment of Multidrug-Resistant Pseudomonas aeruginosa Meningitis.

Authors: Erin K McCreary; Karin E Byers; Carolyn Fernandes; Ellen G Kline; David P Nicolau; Ryan K Shields
Journal: Open Forum Infect Dis Date: 2020-11-12 Impact factor: 4.423

10. An Evidence-Based Multidisciplinary Approach Focused on Creating Algorithms for Targeted Therapy of Infection-Related Ventilator-Associated Complications (IVACs) Caused by Pseudomonas aeruginosa and Acinetobacter baumannii in Critically Ill Adult Patients.

Authors: Milo Gatti; Bruno Viaggi; Gian Maria Rossolini; Federico Pea; Pierluigi Viale
Journal: Antibiotics (Basel) Date: 2021-12-28